EP2252572A1 - Procede de preparation de combretastatine - Google Patents

Procede de preparation de combretastatine

Info

Publication number
EP2252572A1
EP2252572A1 EP20090725421 EP09725421A EP2252572A1 EP 2252572 A1 EP2252572 A1 EP 2252572A1 EP 20090725421 EP20090725421 EP 20090725421 EP 09725421 A EP09725421 A EP 09725421A EP 2252572 A1 EP2252572 A1 EP 2252572A1
Authority
EP
Grant status
Application
Patent type
Prior art keywords
amino
formula
salt
compound
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20090725421
Other languages
German (de)
English (en)
French (fr)
Inventor
Marc Frederic
Sylviane Lutz
Joël MALPART
Philippe Masson
Stéphane Mutti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi-Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/18Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of products other than chlorine, adipic acid, caprolactam, or chlorodifluoromethane, e.g. bulk or fine chemicals or pharmaceuticals
    • Y02P20/55Synthetic design, e.g. reducing the use of auxiliary or protecting groups
EP20090725421 2008-02-28 2009-02-27 Procede de preparation de combretastatine Withdrawn EP2252572A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0801092A FR2928148B1 (fr) 2008-02-28 2008-02-28 Procede de preparation de combretastatine
PCT/FR2009/000215 WO2009118474A8 (fr) 2008-02-28 2009-02-27 Procede de preparation de combretastatine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20120172410 EP2562154A1 (fr) 2008-02-28 2009-02-27 Procédé de preparation de combretastatine

Publications (1)

Publication Number Publication Date
EP2252572A1 true true EP2252572A1 (fr) 2010-11-24

Family

ID=39816950

Family Applications (2)

Application Number Title Priority Date Filing Date
EP20120172410 Withdrawn EP2562154A1 (fr) 2008-02-28 2009-02-27 Procédé de preparation de combretastatine
EP20090725421 Withdrawn EP2252572A1 (fr) 2008-02-28 2009-02-27 Procede de preparation de combretastatine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP20120172410 Withdrawn EP2562154A1 (fr) 2008-02-28 2009-02-27 Procédé de preparation de combretastatine

Country Status (8)

Country Link
US (1) US20110124899A1 (it)
EP (2) EP2562154A1 (it)
JP (1) JP2011513286A (it)
KR (1) KR20100116644A (it)
CN (1) CN102015620A (it)
CA (1) CA2716541A1 (it)
FR (1) FR2928148B1 (it)
WO (1) WO2009118474A8 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
WO2013084150A1 (en) * 2011-12-06 2013-06-13 Sanofi Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
EP3184095A1 (en) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
CN104447598B (zh) * 2013-09-18 2017-09-22 浙江大德药业集团有限公司 Ca‑4的大环多胺衍生物及其抗肿瘤特性
CN104817519B (zh) * 2015-05-11 2016-11-16 中国药科大学 一类ca-4的衍生物、其制法及其医药用途
CN104892668B (zh) * 2015-05-12 2017-03-29 上海大学 考布他汀类似物水溶性前‑前药及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0641767B1 (en) 1993-09-08 1998-12-23 Ajinomoto Co., Inc. Cytotoxic stilbene derivatives and pharmaceutical composition containing them
US5731353A (en) 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
US5561122A (en) 1994-12-22 1996-10-01 Arizona Board Of Regents Acting On Behalf Of Arizona State University Combretastatin A-4 prodrug
JPH08272028A (ja) * 1995-03-30 1996-10-18 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料およびその製造方法
JP2000239274A (ja) * 1998-12-16 2000-09-05 Nippon Kayaku Co Ltd 新規ナフチリジン誘導体の製造法
WO2001045692A9 (en) * 1999-12-21 2002-07-04 Teva Pharma Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
US6759555B2 (en) * 2002-04-11 2004-07-06 Aventis Pharma S.A. Process for the preparation of combretastatins
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
DE10333042B4 (de) * 2003-07-21 2005-09-29 Clariant Gmbh Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2009118474A1 *

Also Published As

Publication number Publication date Type
CN102015620A (zh) 2011-04-13 application
FR2928148B1 (fr) 2013-01-18 grant
CA2716541A1 (fr) 2009-10-01 application
FR2928148A1 (fr) 2009-09-04 application
EP2562154A1 (fr) 2013-02-27 application
WO2009118474A8 (fr) 2010-09-10 application
US20110124899A1 (en) 2011-05-26 application
JP2011513286A (ja) 2011-04-28 application
WO2009118474A1 (fr) 2009-10-01 application
KR20100116644A (ko) 2010-11-01 application

Similar Documents

Publication Publication Date Title
US20090192326A1 (en) Preparation of sitagliptin intermediate
US20050197503A1 (en) Process for the preparation of N-alkyl-N-methyl-3-hydroxy-3-(2-thienyl)-propylamines
JP2004250353A (ja) β−アルコキシプロピオンアミド類の製造方法
US7462738B2 (en) Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
WO2010113939A1 (ja) ジフェニルメタン化合物
WO2005115978A1 (en) Process for the preparation of optically pure 4-hydroxy-2-oxo-1-pyrrolidine acetamide
EP2062874A1 (en) Process and intermediates for the preparation of aliskiren
WO2008047388A2 (en) Improved process for the preparation of ranolazine
WO2010015935A2 (en) Unsaturated cinacalcet salts and processes for preparing cinacalcet hydrochloride
EP0529842A2 (en) Production of fluoxetine and new intermediates
WO2005085178A1 (en) Method of preparing optically active serine derivative
US20030181753A1 (en) Method for producing amides or esters
WO2001077064A1 (en) Method for the preparation of (e)-n-(6,6-dimethyl-2-hepten-4-ynyl)-n-methyl-1-naphthalenemethanamine (terbinafine)
CN1844110A (zh) 高光学纯度的缬沙坦的合成方法
CN103204867A (zh) 手性氨基硼酸酯及制备方法与其在硼替佐米合成中的应用
US8338645B2 (en) Method for producing a β-alkoxypropionamide
WO2006076562A1 (en) Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
US20030220404A1 (en) Process for the preparation of combretastatins
US20060229465A1 (en) Process for the preparation of adapalene
JP2006213712A (ja) ビナフトール誘導体及び光学分割または光学変換のためのその用途
WO2008125592A1 (en) Improved process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation
WO2012004210A1 (en) Process and intermediates for preparation of an active ingredient
WO2007144091A1 (en) Shortened synthesis using paraformaldehyde or trioxane
JP2009185079A (ja) β−アルコキシプロピオンアミド類の製造方法
US20110275855A1 (en) Separation of an enantiomer mixture of (r)- and (s)-3-amino-1-butanol

Legal Events

Date Code Title Description
17P Request for examination filed

Effective date: 20100928

AK Designated contracting states:

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent to

Countries concerned: ALBARS

DAX Request for extension of the european patent (to any country) deleted
RAP1 Transfer of rights of an ep application

Owner name: SANOFI

17Q First examination report

Effective date: 20120215

RAP1 Transfer of rights of an ep application

Owner name: SANOFI

RAP1 Transfer of rights of an ep application

Owner name: SANOFI

18D Deemed to be withdrawn

Effective date: 20130612